Analysts Offer Insights on Healthcare Companies: Myomo (MYO), Ionis Pharmaceuticals (IONS) and Opko Health (OPK)
Piper Sandler Maintains Opko Health(OPK.US) With Buy Rating, Maintains Target Price $3
OPKO Health Analyst Ratings
Barrington Maintains Opko Health(OPK.US) With Buy Rating, Maintains Target Price $2.25
H.C. Wainwright Maintains Opko Health(OPK.US) With Buy Rating, Maintains Target Price $3
H.C. Wainwright Maintains Opko Health(OPK.US) With Buy Rating, Maintains Target Price $3
Buy Rating Justified by Opko Health's Promising OXM Candidate and Strategic Asset Sale
Barrington Maintains Opko Health(OPK.US) With Buy Rating, Maintains Target Price $2.25
Piper Sandler Maintains Opko Health(OPK.US) With Buy Rating, Maintains Target Price $3
Opko Health (OPK) Receives a Buy From Piper Sandler
H.C. Wainwright Maintains Opko Health(OPK.US) With Buy Rating, Maintains Target Price $3
Opko Health's Strategic Moves and Pipeline Progress Prompt Buy Rating
OPKO Health Analyst Ratings
Buy Rating Affirmed for OPKO Health Amid Strategic Partnerships and Promising Pipeline Developments
Opko Health Holds Strong Buy Rating: Financial Resilience and Strategic Growth Fuel Optimism
Piper Sandler Adjusts Price Target on OPKO Health to $3 From $5, Maintains Overweight Rating
OPKO Health Analyst Ratings
Opko Health (OPK) Gets a Buy From Piper Sandler
Analysts' Top Healthcare Picks: Opko Health (OPK), Pharming Group (PHAR)
OPKO Health Analyst Ratings